Skip to contentG
GE HealthCare Technologies Inc.
G
GEHCGE HealthCare Technologies Inc. Released Oct 31, 2023, before the open
10-Q filed Oct 31, 2023, 31 days after period end · 0001932393-23-000125
Q3 2023 · 10-Q
Revenue$4.82B$4.82B+5.4% vs Q3 2022+0.1% vs Q2 2023 Net Income$375.00M$375.00M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GE HealthCare Technologies Inc. · CIK 1932393 · Engraved from SEC EDGAR
−10.3% vs Q2 2023
EPS Diluted$0.82$0.82−23.4% vs Q3 2022−9.9% vs Q2 2023 Gross Profit$1,935,000,000+9.1% Operating Income$617,000,000+2.0% Operating Cash Flowderived$650,000,000+4.5% Free Cash Flowderived$570,000,000+4.0% Margins · derivedGross margin40.1%+1.4 pt vs Q3 2022
Operating margin12.8%−0.4 pt vs Q3 2022
Net margin7.8%−2.9 pt vs Q3 2022
ended Sep 30, 2023 · filed Oct 31, 2023 · 31 d after period end